Article

Daily Medication Pearl: Glipizide (Glucotrol)

Glipizide stimulates beta cells to produce more insulin in the body.

Medication Pearl of the Day: Glipizide (Glucotrol)

Indication: Glipizide is an oral blood-glucose-lowering drug of the sulfonylurea class.

Insight:

  • Dosing: The recommended starting dose is 5 mg, given before breakfast. Geriatric patients or those with liver disease may be started on 2.5 mg.
  • Dosage forms: 5 mg and 10 mg
  • Adverse events: Includes gastrointestinal disturbances, erythema, low blood sugars, leukopenia, hyponatremia, dizziness, and drowsiness.
  • Mechanism of action: Glipizide stimulates the beta cells of the pancreas to produce more insulin in the body.
  • Manufacturer: Pfizer

Sources:

label (fda.gov)

glucotrol image - Google Search

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Image credit:  Artur | stock.adobe.com
Cardiovascular disease doctor or cardiologist holding red heart in clinic or hospital exam room office for csr professional medical service, cardiology health care and world heart health day concept - Image credit: Chinnapong | stock.adobe.com
Image credit: AwieDarwis | stock.adobe.com
Image credit: viperagp | stock.adobe.com
Image credit:  kitsawet | stock.adobe.com
Inflammation concept, inflammated human tissues 3d rendering - Image credit: picture-waterfall | stock.adobe.com